language_icon
EN
HI

Samrat Pharmachem Share price

SAMRATPH

202

0.95 (0.47%)
Last updated on 20 Feb, 2026 | 14:49 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

205.00

Today's Low

200.00

52 Week Low

195.10

52 Week High

425.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Samrat Pharmachem Chart

Samrat Pharmachem Share Key Metrics

Volume
3321.00
Market Cap
62.12 CR
LTQ@LTP
90@202.00
ATP
201.37
Var Margin
25 %
Circuit Range
160.85-241.25
Delivery %
0 %
Value
6.69 L
ASM/GSM
No
Market Lot
1

Summary

At 20 Feb, 2026 | 14:49, Samrat Pharmachem share price stands at ₹202, showing a 0.95% 0.47 for the day. The stock’s intraday movement has stayed between ₹200.00 and ₹205.00, while on a 52-week basis it has fluctuated from ₹195.10 to ₹425.00.
In terms of trading activity, Samrat Pharmachem has recorded a volume of 3321 shares, with a market capitalisation of ₹3089700. The stock’s Average Traded Price (ATP) stands at ₹20137, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 90,20200. The stock operates within a circuit range of ₹160.85-241.25, with a Value of ₹6.69 L. The Delivery Percentage for the day is %. Additionally, Samrat Pharmachem currently falls under the No framework, and trades with a market lot size of 1.

Samrat Pharmachem Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

63.23

Sector P/B

2.76

Sec. Div. Yield

0.57

Samrat Pharmachem Resistance and Support

Pivot 203.18

Resistance

First Resistance

206.36

Second Resistance

211.68

Third Resistance

214.86

Support

First Support

197.86

Second Support

194.68

Third Support

189.36

Samrat Pharmachem Futures & Options

Data Not Found

Samrat Pharmachem Shareholding Pattern

View More
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2025-26
  • 2024-25
  • 2019-20
  • 2018-19
  • 2016-17
Total Promoters
Segment
Percent

Total Promoters

49.09%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

3.24%

Retail

47.67%

Others

0%

Total Promoters
MAR '25
49.09%
JUN '25
49.09%
SEP '25
49.09%
DEC '25
49.09%

Samrat Pharmachem Corporate Actions

DateAgenda
2026-02-13Quarterly Results
2025-11-14Quarterly Results
2025-08-13Quarterly Results
2025-05-30Audited Results & Final Dividend
2025-02-14Quarterly Results

Samrat Pharmachem News

No Data Found

About Samrat Pharmachem

NSE : 0  
BSE : 530125  
ISIN : INE103E01016  

Samrat Phannachem Limited was incorporated as Private LimitedCompany on 16th June 1992 under the Companies Act 1956 in theState of Gujarat and subsequently converted into a publiclimited company on 24th July 1992. Samrat Pharmachem Limited isgoing for an expansion of its facilities for manufacture of BulkDrugs at Ankleshwar Gujarat it has taken over the unitcomprising of land & building machinery and other assets andliabilities costing Rs.30.64 lacs from M/s. Lub-chem Bombay apartnerahip firm promoted by the same management at book valueon 1st April 1993.THE MAIN OBJECTS OF THE COMPANYThe main objects of the company as set out in the Memorandum &Articles of Association are as follows:To carry on the business as manufacturers manufacturer''srepresentatives dealers traders factors agents suppliersstockists packers distributors exporters and importers ofall kinds types nature and description of medicine drugsdrug intermediates pharmaceuticals mixtures powders tabletscapsules injunctions compounds formulations nutrientshealth products creams lotions syrups tonics biological andbiochemical products pills mother tinctures triturationsglucose nourishment foods ointment surgical dressings waterfor injections and medical preparations required for or used inallopathic ayurvedic unani homeopathic and nature curetreatments for prevention or prophylactic cure for human beingsanimals insects and birds.SUBSIDIARIESThe company does not have any subsidiary at present.PRESENT BUSINESS OF THE COMPANYThe Company is currently engaged in the manufacture and exportof pharmaceutical bulk drugs namely Potassium Iodide IPPotassium Iodate IP Iodine IP and Ferrous Fumerate IP. TheCompany has achieved a turnover of Rs.153.51 lacs and cashprofit of Rs. 8.79 lacs during the five month period ended 31stAugust 1994.The Company exports its goods to Singapore Japan U.S.A. andother countries. For the year ended March 1994 the Company hasachieved direct and indirect exports worth Rs. 35.59 lacs. Forperiod from April 1994 to August 1994 it has achieved directexports worth Rs. 12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters.

Read More

Samrat Pharmachem Management

NamePosition
Mr. Lalit Mehta Chairman & Managing Director
Mr. Rajesh Mehta Executive Director & CFO
View More

Samrat Pharmachem FAQs

The Buying Price of Samrat Pharmachem share is 202 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Samrat Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Samrat Pharmachem, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Samrat Pharmachem shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Samrat Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.

To assess Samrat Pharmachem’s valuation compare Sector P/E, P/B which are 63.23 & 2.76 with sector averages, along with growth rates and financial metrics.

The Market Cap of Samrat Pharmachem is 62.12 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Samrat Pharmachem share price is 425.00 & 195.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Samrat Pharmachem belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost